Annual Congress Glasgow 2004

Saturday, 04.09.2004
Sunday, 05.09.2004
Monday, 06.09.2004
Tuesday, 07.09.2004
Wednesday, 08.09.2004

Citations should be made in the following way: Authors. Title. Eur Respir J 2004; 24: Suppl. 48, abstract number.

Material from 2004:

3888 Abstracts
555 Slide presentations
20 Webcasts
96 Handouts

Material from 2004: Show

Targeting acute and chronic airway obstruction

Thematic Poster Session
Chairs: G. Di Maria (Catania, Italy), N. Hanania (Houston, United States Of America)

Download all media

Polymorphism of β2-adrenergic receptor (β2-AR) and regular use of long-acting β-agonists in asthma L. Fuso, R. Antonelli Incalzi, A. Longobardi, S. Basso, A. Trovè, C. Brahe, C. Angelozzi, R. Pistelli (Rome, Italy)
Airway responsiveness to beta-adrenergic agonist in smokers M. H. Boskabady, H. H. Farhadi (Mashhad, Iran)
Bronchodilator reversibility and short-term inhaled corticosteroid response in Japanese patients with COPD N. Sato, K. Kurashima, N. Takayanagi, M. Nagata, K. Hagiwara, M. Kanazawa (Moroyama, Saitama, Japan)
Bronchodilator response to formoterol (FOR) after regular tiotropium (TIO) or to TIO after regular FOR in COPD patients P. Noschese, A. Salzillo, C. De Giglio, G. D‘Amato, M. G. Matera, M. Cazzola (Naples, Italy)
The effect of combined β2-agonist and anticholinergic inhaled therapy in patients with COPD Z. Arsovski, D. Dokic, M. Boskovska, Z. Goseva, B. Kaeva, L. Gligorovski, M. Gavrilovski (Skopje, Macedonia)
FEV₆: a useful outcome measure of lung function in COPD as assessed in a large clinical study with roflumilast D. O‘Donnell, K. F. Rabe, C. Jenkins, J. F. Muir, S. Witte, D. Bredenbroeker (Kingston, Canada; Leiden, The Netherlands; Camperdown, Australia; Rouen, France; Konstanz, Germany)
Basal FEV₁ does not predict the long term response to salmeterol/fluticasone in COPD C. Terzano, A. Petroianni, A. Ricci, S. Mariotta, L. Allegra, M. Cazzola (Rome, Milan, Naples, Italy)
Salmeterol/fluticasone therapy improves FEV₁ in mild and moderate more than in severe COPD patients C. Terzano, A. Petroianni, A. Ricci, S. Mariotta, L. Allegra, M. Cazzola (Rome, Milan, Naples, Italy)
Comparative study of two years treatment with salmeterol alone and in combination with ipratropium bromide and beclometazone dipropionate in patients with chronic obstructive pulmonary disease (COPD) D. V. Djordjevic, I. J. Stankovic, T. A. Pejcic, M. H. Rancic, L. M. Ristic, M. M. Radovic (Nis, Serbia & Montenegro)
The effects of a crossover treatment with inhaled corticosteroids and N-acetylcysteine on lung function parameters in COPD-patients F. J. van Overveld, D. Gòrecka, U. A. Demkow, A. Nowinski, P. Bielen, D. Kaminski, E. Puscinska, A. Goljan, J. Kolakowski, W. A. De Backer, J. Zielinski (Antwerpen, Belgium; Warsaw, Poland)
Enoxaparin elicits an effect on lung function and blood gas levels in patients with COPD M. Cazzola, L. Allegra, M. G. Matera, C. P. Page (Naples, Milan, Italy; London, United Kingdom)
A single centre double-blind placebo controlled pilot study into the use of intravenous magnesium sulphate for the treatment of acute exacerbation of chronic obstructive airways disease (COPD) J. S. Hogg, S. A. Mulrennan, C. Everett, A. H. Morice (Hull, United Kingdom)
A randomized clinical trial of magnesium sulfate as a vehicle for nebulized salbutamol in the treatment of moderate to severe asthma attacks H. Turktas, N. Kokturk, P. Kara, S. B. Mullaoglu, F. Yilmaz, A. Karamercan (Ankara, Turkey)
Aerosolized budesonide therapy in acute moderate exacerbations of Indian asthmatics S. K. Agarwal (Varanasi, India)
Comparison of formoterol and terbutaline for treatment of asthma exacerbations in children and adolescents M. H. Bussamra, R. Stelmach, J. Rodrigues, A. Cukier (Sao Paulo, Brazil)
Inhaled formoterol in the treatment of acute asthma exacerbation at emergency room I. Solarte, C. Villaquiran, Y. Sanchez (Bogota, Colombia)
Add on therapy of pure theophylline sollution with systemic corticosteroid is more effective for the treatment of asthma attack M. Kato, K. Masago (Kishiwada, Japan)
Comparison of treatments with nebulised salbutamol and epinephrine in acute bronchiolitis F. Gurkan, H. Tuzun, A. Ece, K. Haspolat, M. Bosnak, B. Dikici (Diyarbakir, Turkey)
Budesonide/formoterol single inhaler therapy reduces overreliance on rapid-acting reliever medication A. Balanzat, S. Centanni, M. Palmqvist, K. Rabe (Buenos Aires, Argentina; Milan, Italy; Gothenburg, Sweden; Leiden, The Netherlands)
Cost of asthma rescue/acute and allergy medications among asthmatic patients on controller therapy N. Travier, V. S Kocevar, D. D. Yin, L. Laforest, E. Van Ganse (Pierre-Bénite, France; Whitehouse Station, United States Of America)